Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine

Authors

  • Da-Yong Lu School of Life Sciences, Shanghai University, Shanghai200444, China
  • Swathi Putta Department of Pharmacology, Raghu College of Pharmacy, India
  • Jin-Yu Che School of Life Sciences, Shanghai University, Shanghai200444, China

DOI:

https://doi.org/10.37155/2972-449X-vol1(3)-91

References

Lu DY, Lu TR, Wu HY, et al. Cancer Metastasis treatments. Current Drug Therapy, 2013; 8(1): 24-29.

Lambert, AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell, 2017, 168, 670-691.

Lu DY, Xu B. Bone cancer and metastatic trials, drug treatment. Acta Scientific Orthopaedics; 2021, 4(9), 31-33. 10.31080/ASR2021.04.0355.

Bhadresha KP, Patel M, Jain NK, et al. A predictive biomarker panel for bone metastasis, liquid biopsy approach. J Bone Oncology; 2021, 29, 100371.

Lu DY, Xu B. Cancer bone metastasis, experimental study. Acta Scientific Orthopeadics; 2022, 5(12), 1-3.

Lu DY. Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. 2014, Woodhead Publishing, Elsevier, UK (ISBN. 978-0-08-100346-6)

Lu DY, Lu TR, Che JY, et al. Individualized cancer therapy, future approaches. Current Pharmacogenomics & Personalized Medicine; 2018, 16(2), 156-163.

Eslami-S Z, Cortes-Hernandez LE, Thomas F, et al. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade. Brit J Cancer, 10.1038/s4146-022-01819-1.

Pantel K, Alix-Panabieres C. Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation. J Immuno Therapy of Cancer, 2022, 10, e005615. 10.1136/jitc-2022-005615.

Lu DY, Lu TR, Yarla NS, et al. Drug sensitivity testing for cancer therapy, key areas. Reviews on Recent Clinical Trials, 2022, 17(4), 291-299.

Lu DY, Lu TR. Drug sensitivity testing, a unique drug selection strategy. Advances in Biomarker Sciences and Technology, 2020, 2, 59-66.

Lu DY, Qi RX, Lu TR, et al. Cancer bioinformatics for update anticancer drug developments and personalized therapeutics. Reviews on Recent Clinical Trials, 2017, 12(2), 101-110.

Lu DY, Lu TR, Xu B, et al. Pharmacogenetics of cancer therapy: breakthroughs from beyond? Future Science OA, 2015, 1(4), FSO.15, 80.

Barani M, Mukhtar M, Rahdar A, et al. Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma. Biosensors, 2021, 11, 55 10.3390/bios11020055.

Downloads

Published

19-12-2023

How to Cite

Lu, D.-Y., Putta, S., & Che, J.-Y. (2023). Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine. BME Horizon, 1(3). https://doi.org/10.37155/2972-449X-vol1(3)-91

Issue

Vol. 1 No. 3 (2023)

Section

Editorial

License

Copyright (c) 2023 Da-Yong Lu, Swathi Putta, Jin-Yu Che

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright on any open-access article in a journal published by Globasci Publishing House Pte. Ltd. is retained by the authors. Authors grant Globasci Publishing House Pte. Ltd. a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. The Creative Commons Attribution-NonCommercial 4.0 International License formalizes these and other terms and conditions of publishing articles.